References
1. Rozkovec A., MontanesP., Oakley C.M. Factors that influence the outcome of primary pulmonary hypertension. Br. Heart J. 1986; 55: 449-58.
2. Hopkins W.E., Ochoa L.L., Richardson G.W., Trulock E.P. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J. Heart Lung Transplant. 1996; 15 (1, part 1): 100-5.
3. Austen W.G., Morrow A.G., Berry W.B. Experimental studies of the surgical treatment of primary pulmonary hypertension. J. Thorac. Cardiovasc. Surg. 1964; 48: 448-55.
4. Collins T.J., Moore J.W., Kirby W.C. Atrial septostomy for pulmonary hypertension. Am. Heart J. 1988; 116: 873-4.
5. Rashkind W.J., Miller W.W. Creation of an atrial septal defect without thoracotomy: a palliative approach to complete transposition of the great arteries. JAMA. 1966; 196: 991-2.
6. Rich S., Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. Am. J. Cardiol. 1983; 51: 1560-1.
7. Keogh A.M., Mayer E., Benza R.L., Corris P, Dartevelle P.G., Frost A.E. et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J. Am. Coll. Cardiol. 2009; 54 (1, suppl.): S67-77.
8. Maluli H.A., DeStephan C.M., Alvarez R.J., Sandoval J. Atrial
septostomy: A contemporary review. Clin. Cardiol. (in press). Available at: http://www. wileyonlinelibrary.com/
10.1002/clc.22398.
9. Габисония Л.М., Горбачевский С.В., Косенко А.И. Роль ат- риосептостомии при лечении больных с критической легочной гипертензией и интактными перегородками сердца. Детские болезни сердца и сосудов. 2006; 4: 16-9.
10. Горбачевский С.В., Толстых М.В. Атриосептостомия в лечении пациентов с первичной (идиопатической) легочноартериальной гипертензией. Детские болезни сердца и сосудов. 2011; 1: 9-14.
11. Weimar T., Watanabe Y., Kazui T., Lee U.S., Montecalvo A., Schuessler R.B. et al. Impact of differential right-to-left shunting on systemic perfusion in pulmonary arterial hypertension. Cathet. Cardiovasc. Interv. 2013; 81(5): 888-95.
12. Galie' N., HoeperM.M., Humbert M., Torbicki A., Vachiery J.L. Barbera J.A. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2009; 30: 2518.
13. Galie' N., Corris P.A., Frost A, Girgis R.E., Granton J., Jing Z.C. et al. Updated treatment algorithm of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 2013; 62 (25 suppl.): D60-72.
14. Sandoval J., Gaspar J, Pulido T., Bautista E., Martfnez- Guerra M.L., Zebalos M. et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: a therapeutic alternative for patients nonresponsive to vasodilator treatment. J. Am. Coll. Cardiol. 1998; 32: 297-304.
15. Sandoval J., Gaspar J. Atrial septostomy. In: Peacock A.J., Rubin L.J. (eds). Pulmonary Circulation. 2nd ed. London: Edward Arnold; 2004: 319-33.
16. Sandoval J., Gaspar J., Pena H., Santos L.E., Cordova J., del Valle K. et al. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur. Respir. J. 2011; 38: 1343-8.
17. Chiu S., Zuckerman W.A., Turner M.E., Richmond M.E., Kerstein D., Krishnan U. et al. Balloon atrial septostomy in pulmonary arterial hypertension: Effect on survival and associated outcomes. J. Heart Transplant. Available at: http://dx.doi.org/10.1016/j.healun.2015.01.004.
18. Reichenberger F., Pepke-Zaba J., McNeil K., Parameshwar J., Shapiro L.M. Atrial septostomy in the treatment of severe pulmonary arterial hypertension. Thorax. 2003; 58: 797-800.
19. Ali Khan M.A., Bricker J.T., Mullins C.E., Yousef S., Ni- hill M.R., Vargo T.A. et al. Blade atrial septostomy: experience with the first 50 procedures. Cathet. Cardiovasc. Diagn. 1991; 23: 257-62.
20. Fraisse A, Chetaille P., Amin Z., Rouault F., Humbert M. Use of Amplatzer fenestrated atrial septal defect device in a child with familial pulmonary hypertension. Pediatr. Cardiol. 2006; 27: 759-62.
21. O’loughlin A.J., Keogh A., Muller D.W. Insertion of a fenestrated Amplatzer atrial septostomy device for severe pulmonary hypertension. Heart Lung Circ. 2006; 15: 275-7.
22. Prieto L.R., Latson L.A., Jennings C. Atrial septostomy using a butterfly stent in a patient with severe pulmonary arterial hypertension. Cathet. Cardiovasc. Interv. 2006; 68: 642-7.
23. Althoff T.F., Knebel F, Panda A., McArdle J., Gliech V., FrankeI. et al. Long-term follow-up of a fenestrated Amplatzer atrial septal occlude in pulmonary arterial hypertension. Chest. 2008; 133; 283-5.
24. Troost E., Delcroix M., Gewillig M., Van Deyk K., Budts W. A modified technique of stent fenestration of the interatrial septum improves patients with pulmonary hypertension. Cathet. Cardiovasc. Interv. 2009; 73: 173-9.
25. Roy A.K., GaineS.P, Walsh K.P. Percutaneous atrial septostomy with modified butterfly stent and intracardiac echocardio- graphic guidance in a patient with syncope and refractory pulmonary arterial hypertension. Heart Lung Circ. 2013; 22 (8): 668-71.
26. Sager J.S., Ahya V.N. Surgical therapies for pulmonary arterial hypertension. Clin. Chest Med. 2007; 28: 187-202.
27. Unger P, Stoupel E., Vachiery J.L., De Backer D. Atrial septostomy under transesophageal guidance in a patient with primary pulmonary hypertension and absent right superior vena cava. Intensive Care Med. 1996; 22: 1410-11.
28. Bidoggia H., Maciel J.P., Alvarez J.A. Transseptal left heart catheterization: usefulness of the intracavitary electrocardiogram in the localization of the fossa ovalis. Cathet. Cardiovasc. Diagn. 1991; 24: 221-5.
29. Moscucci M., Dairywala I.T., Chetcuti S., Mathew B., Li P., Rubenfire M. et al. Balloon atrial septostomy in end-stage pulmonary hypertension guided by a novel intracardiac echocar- diographic transducer. Cathet. Cardiovasc. Interv. 2001; 52: 530-4.
30. Raval A.N., Karmarker P.V., Guttman M.A. Real-time MR1- guided atrial septal puncture and balloon septostomy in swine. Cathet. Cardiovasc. Interv. 2006; 67: 637-43.
31. Sakata Y, Feldman T. Transcatheter creation of atrial septal perforation using a radiofrequency transseptal system: novel approach as an alternative to transseptal needle puncture. Cathet. Cardiovasc. Interv. 2005; 64: 327-32.
32. McLaughlin V.V., Archer S.L., Badesch D.B., Barst R.J., Farber H.W., Lindner J.R. et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, 1nc., and the Pulmonary Hypertension Association. J. Am. Coll. Cardiol. 2009; 53: 1573-619.
33. Micheletti A., Hislop A., Lammers A., Bonhoeffer P., Derrick G., Rees P. et al. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart. 2006; 92: 969-72.
34. Sandoval J., Rothman A., Pulido T. Atrial septostomy for pulmonary hypertension. Clin. Chest Med. 2001; 22: 547-60.
35. Roelke M., Smith A.J., Palacios I.F. The technique and safety of transseptal left heart catheterization: the Massachusetts General Hospital experience with 1279 procedures. Cathet. Cardiovasc. Diagn. 1994; 32: 332-9.
36. Bhamra-Ariza P, Keogh A.M., Muller D.W. Percutaneous interventional therapies for the treatment of patients with severe pulmonary hypertension. J. Am. Coll. Cardiol. 2014; 63: 611-8.
37. Kurzyna M., Dabrowski M., Bielecki D, Fijalkowska A., Pruszczyk P, Opolski G. et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest. 2007; 131: 977-83.
38. Vachiery J.L., Stoupel E., Boonstra A., Naeije R. Balloon atrial septostomy for pulmonary hypertension in the prostacyclin era (abstr.). Am. J. Respir. Crit. Care Med. 2003; 167: A692.
39. Allcock R.J., O’Sullivan J.J., Corris P.A. Atrial septostomy for pulmonary arterial hypertension. Heart. 2003; 89: 1344-7.
40. O’Byrne M.L., Rosenzweig E.S., Barst R.J. The effect of atrial septostomy on the concentration of brain-type natriuretic peptide in patients with idiopathic pulmonary arterial hypertension. Cardiol. Young. 2007; 17: 557-9.
41. Rich S., Dodin E., McLaughlin V.V. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am. J. Cardiol. 1997; 80: 369-71.
42. Barst R.J. Role of atrial septostomy in the treatment of pulmonary vascular disease [published correction appears in Thorax. 2000; 55: 254]. Thorax. 2000; 55: 95-6.
43. Espinola-Zavaleta N., Vargas-Barron J., Tazar J.I., Casanova J.M., Keirns C., Cardenas A.R. et al. Echocardiographic evaluation of patients with primary pulmonary hypertension before and after atrial septostomy. Echocardiography. 1999; 16 (7, part 1): 625-34.
44. Hopkins W.E. The remarkable right ventricle of patients with Eisenmenger syndrome. Coronary Artery Dis. 2005; 16: 19-25.
45. Bristow M.R., Zisman L.S., Lowes B.D., Abraham W.T., Badesch D.B., Groves B.M. et al. The pressure-overloaded right ventricle in pulmonary hypertension. Chest. 1998; 114 (1, suppl): 101S-6S.
46. Ciarka A., Vachiery J., Houssiere A., Gujic M., Stoupel E., Velez-Roa S. et al. Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertension. Chest. 2007; 131: 1831-7.
47. Velez-Roa S., Ciarka A., Najem B., Vachiery J.L., Naeije R., van de Borne P. 1ncreased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004; 110: 1308-12.
48. Tapson V. Atrial septostomy. Why we still need it? Chest. 2007; 131: 947-8.